Concepedia

Publication | Open Access

Immunosuppressive Therapy and Risk of COVID-19 Infection in Patients With Inflammatory Bowel Diseases

64

Citations

33

References

2020

Year

Abstract

The use of systemic immunosuppression was not associated with an increased risk of COVID-19 in a multi-institutional cohort of patients with IBD.

References

YearCitations

Page 1